C113H126N32O17S2 — CID 158238072
4-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]morpholine-2-carboxamide;1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyrrolidine-2-carboxamide;2,4-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,3-thiazole-5-carboxamide;2-methoxy-5-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]morpholine-4-carboxamide (PubChem CID 158238072) has the molecular formula C113H126N32O17S2 and a molecular weight of 2268.59 g/mol. Its IUPAC name is 4-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]morpholine-2-carboxamide;1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyrrolidine-2-carboxamide;2,4-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,3-thiazole-5-carboxamide;2-methoxy-5-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]morpholine-4-carboxamide.
| Compound Name | 4-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]morpholine-2-carboxamide;1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyrrolidine-2-carboxamide;2,4-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,3-thiazole-5-carboxamide;2-methoxy-5-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]morpholine-4-carboxamide |
|---|---|
| PubChem CID | 158238072 |
| Molecular Formula | C113H126N32O17S2 |
| Molecular Weight | 2268.59 g/mol |
| Exact Mass | 2266.94 |
| IUPAC Name | 4-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]morpholine-2-carboxamide;1-benzyl-N-[5-(5,6-dimethoxy-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyrrolidine-2-carboxamide;2,4-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1,3-thiazole-5-carboxamide;2-methoxy-5-methylsulfonyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]morpholine-4-carboxamide |
| SMILES | COc1cc2nc(-c3[nH]ncc3NC(=O)C3CCCN3Cc3ccccc3)[nH]c2cc1OC.COc1cc2nc(-c3[nH]ncc3NC(=O)C3CN(Cc4ccccc4)CCO3)[nH]c2cc1OC.COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1.Cc1nc(C)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)s1.O=C(Nc1cn[nH]c1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)N1CCOCC1 |
| InChI | InChI=1S/C24H26N6O5S.C24H26N6O4.C24H26N6O3.C21H23N7O2S.C20H25N7O3/c1-34-21-6-4-16(36(2,32)33)12-17(21)24(31)28-20-13-25-29-22(20)23-26-18-5-3-15(11-19(18)27-23)14-30-7-9-35-10-8-30;1-32-19-10-16-17(11-20(19)33-2)27-23(26-16)22-18(12-25-29-22)28-24(31)21-14-30(8-9-34-21)13-15-6-4-3-5-7-15;1-32-20-11-16-17(12-21(20)33-2)27-23(26-16)22-18(13-25-29-22)28-24(31)19-9-6-10-30(19)14-15-7-4-3-5-8-15;1-12-19(31-13(2)23-12)21(29)26-17-10-22-27-18(17)20-24-15-4-3-14(9-16(15)25-20)11-28-5-7-30-8-6-28;28-20(27-5-9-30-10-6-27)24-17-12-21-25-18(17)19-22-15-2-1-14(11-16(15)23-19)13-26-3-7-29-8-4-26/h3-6,11-13H,7-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);3-7,10-12,21H,8-9,13-14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);3-5,7-8,11-13,19H,6,9-10,14H2,1-2H3,(H,25,29)(H,26,27)(H,28,31);3-4,9-10H,5-8,11H2,1-2H3,(H,22,27)(H,24,25)(H,26,29);1-2,11-12H,3-10,13H2,(H,21,25)(H,22,23)(H,24,28) |
| InChIKey | GFFDGZYEVZQEJU-UHFFFAOYSA-N |
| XLogP | 13.59 |
| TPSA | 591.07 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 164 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2268.59 |
| LogP ≤ 5 | 13.59 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 34 |